Michael Gerhold BSc, MSBME, MBA

Michael Gerhold, Head of Commercial Analytics, Neurocrine Biosciences. Michael is the Head of Commercial Analytics at Neurocrine Biosciences. In his role, Michael oversees a team that provides market research and analytics support for newly launched INGREZZA as well as life cycle management opportunities.

Prior to joining Neurocrine Biosciences, Michael was at Otsuka Pharmaceuticals where he provided market research insights to the successful HCP and DTC launch of Rexulti, a novel antipsychotic. Michael has over 15 years of experience working in a variety of roles in market research, marketing, analytics and forecasting supporting in-line brand teams, life cycle management, and business development.

Michael holds a MBA and Master of Science in Biomedical Engineering from Purdue University and a BS in Biophysics from University of California San Diego. Michael is originally from San Diego, California.